PRCT Q2 2021 Earnings — PROCEPT BioRobotics Corporation Revenue & Financial Results | Market Cap Arena

PRCTPROCEPT BioRobotics Corporation

$1B

Q2 2021 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$8M+609.6% YoY

Gross Profit

$4M42.3% margin

Operating Income

-$13M-155.6% margin

Net Income

-$15M-172.0% margin

EPS (Diluted)

$-0.35

QoQ Revenue Growth

+17.9%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$725,000

Balance Sheet

Total Assets

$191M

Total Liabilities

$397M

Stockholders' Equity

-$206M

Cash & Equivalents

$159M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$1M	+609.6%
Gross Profit	$4M	-$846,500	+523.3%
Operating Income	-$13M	-$12M	-11.7%
Net Income	-$15M	-$13M	-13.3%